Capsida Biotherapeutics
Engineering novel AAVs and developing the next generation of gene therapies
47 employees · est. 2019 · United States
BioPact is the older company (2014 vs 2019); Capsida Biotherapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | BioPact | Capsida Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2019 |
| Headquarters | ||
| Headquarters | Austin, United States | United States |
| Employees | ||
| Employees | 5 | 47 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $140.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Not tracked yet | Developing targeted genetic medicines, Capsid engineering for disease targets, cGMP manufacturing of gene therapies, Collaborations with major biopharmaceutical companies |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare neurological and ocular diseases, Biopharmaceutical companies seeking partnerships, Healthcare professionals in genetics and neurology |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Gene Therapy, AAV Engineering, Genetic Disorders, Targeted Delivery, Non-Invasive Therapies, Neurologic Diseases, Patent Portfolio, Strategic Collaborations, Translational Biology, Multimodality Cargo Development, Process Development, Biopharmaceuticals, AAV Immunology, Clinical Development |
| Website | ||
| Website | bio-pact.com | capsida.com |
About BioPact
Biopact is a Molecular Rebar Design Company focusing on nanoscale biomaterials company developing the MGMR intracellular delivery vehicle. MGMR is a cellular-engineering tool for biomanufacturing and agricultural processes which value efficient delivery of RNAs, peptides, and genetic materials. MGM...
About Capsida Biotherapeutics
Capsida Biotherapeutics Inc., founded in 2019, is making breakthroughs in the biotechnology and pharmaceutical industries. The company's mission, summarized by its slogan, "Engineering novel AAVs and developing the next generation of gene therapies," highlights its pioneering approach to creating ta...
We will tell you when either one moves
BounceWatch watches BioPact and Capsida Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioPact and Capsida Biotherapeutic... — by email.
Frequently Asked Questions
Compare BioPact with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BioPact on 13 Sep 2024, and Capsida Biotherapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.